Title : Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response.

Pub. Date : 2018 Aug

PMID : 30033448






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Angiopoietin-like protein 3 blocks nuclear import of FAK and contributes to sorafenib response. Sorafenib angiopoietin like 3 Homo sapiens
2 Loss-of-function and gain-of-function experiments were performed to investigate the biological roles of ANGPTL3 in response to sorafenib treatment in RCC cells. Sorafenib angiopoietin like 3 Homo sapiens
3 RESULTS: ANGPTL3 was upregulated in sorafenib-responsive RCC, which correlated with clinically good sorafenib response. Sorafenib angiopoietin like 3 Homo sapiens
4 RESULTS: ANGPTL3 was upregulated in sorafenib-responsive RCC, which correlated with clinically good sorafenib response. Sorafenib angiopoietin like 3 Homo sapiens
5 Knockdown of ANGPTL3 conferred sorafenib-tolerance traits to RCC cells, whereas overexpression of ANGPTL3 restored sorafenib sensitivity in RCC cells. Sorafenib angiopoietin like 3 Homo sapiens
6 Mechanistically, ANGPTL3 bound to Focal Adhesion Kinase(FAK) and restained sorafenib induced nuclear translocation of FAK, leading to attenuate the ubiquitination of p53, which contributed to cellular apoptosis and enhanced sorafenib response. Sorafenib angiopoietin like 3 Homo sapiens
7 Mechanistically, ANGPTL3 bound to Focal Adhesion Kinase(FAK) and restained sorafenib induced nuclear translocation of FAK, leading to attenuate the ubiquitination of p53, which contributed to cellular apoptosis and enhanced sorafenib response. Sorafenib angiopoietin like 3 Homo sapiens
8 CONCLUSIONS: ANGPTL3 may be a novel predictor for the response of sorafenib therapy in RCC patients, and a potential target in improving its therapeutic effect. Sorafenib angiopoietin like 3 Homo sapiens